ENTtoday
  • Home
  • COVID-19
  • Practice Focus
    • Allergy
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
  • Departments
    • Issue Archive
    • TRIO Best Practices
      • Allergy
      • Facial Plastic/Reconstructive
      • Head and Neck
      • Laryngology
      • Otology/Neurotology
      • Pediatric
      • Rhinology
      • Sleep Medicine
    • Career Development
    • Case of the Month
    • Everyday Ethics
    • Health Policy
    • Legal Matters
    • Letter From the Editor
    • Medical Education
    • Online Exclusives
    • Practice Management
    • Resident Focus
    • Rx: Wellness
    • Special Reports
    • Tech Talk
    • Viewpoint
    • What’s Your O.R. Playlist?
  • Literature Reviews
    • Allergy
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
  • Events
    • Featured Events
    • TRIO Meetings
  • Contact Us
    • About Us
    • Editorial Board
    • Triological Society
    • Advertising Staff
    • Subscribe
  • Advertise
    • Place an Ad
    • Classifieds
    • Rate Card
  • Search

Recurrent Respiratory Papillomatosis: Researchers Advancing Toward Prevention

by John Austin • September 1, 2006

  • Tweet
  • Email
Print-Friendly Version

When it comes to cidofovir, although scientists are not entirely sure exactly how it works, they know that it inhibits the viral DNA polymerase and it definitely targets rapidly dividing cells.

You Might Also Like

  • Pediatric Recurrent Respiratory Papillomatosis: Fighting the Battle of a Rare But Serious Disease
  • Suspect Adult Respiratory Papillomatosis with Recurrent Hoarseness after Surgery
  • Recurrent Respiratory Papillomatosis: Much Has Been Done, but a Long Road Lies Ahead
  • Prevalence of Dysplasia with Recurrent Respiratory Papillomatosis Is High
Explore This Issue
September 2006

One important thing to remember is the RRP is different in juvenile disease than it is in adult disease and, consequently, when you look at the literature, you tend to see much different response rate in adults than in children, he said. The tendency we see is that adults seem to respond better to cidofovir, perhaps because their presentation of disease is generally far less severe.

The main issue, and the 800-pound gorilla when it comes to cidofovir, is the question of toxicity-the carcinogenesis of cidofovir.

The concern is that you’re injecting this medicine into the cells, it’s being taken up by the cells, and it may disrupt the genomic integrity of the cell and that’s what ultimately may generate a problem with progressive dysplasia, Dr. Pransky said. It’s difficult to know whether what we’re seeing is the natural history of the disease that might be particularly severe, or if the cidofovir is actually acting as an agent bringing about the changes.

Prevention on the Horizon?

The most promising glimpse into the future of RRP, however, does not involve treatment-it’s about prevention and the development of two extremely promising vaccines: the quadrivalent Gardasil, which recently received FDA approval, and the bivalent vaccine Cervarix, which is expected to be submitted for approval later this year.

Early trials have been so successful that things are moving ahead fairly quickly with both of these vaccines, Dr. Pransky said. We hope they will pave the way to make RRP a disease of the past. This is where the future is and where we will need to focus a lot of our efforts.

©2006 The Triological Society

Pages: 1 2 3 4 | Single Page

Filed Under: Departments, Laryngology, Medical Education, Pediatric, Practice Focus Tagged With: cancer, HPV, medication, pediatrics, pharmaceuticals, prevention, respiratory papillomatosis, surgery, treatment, vaccine, virusIssue: September 2006

You Might Also Like:

  • Pediatric Recurrent Respiratory Papillomatosis: Fighting the Battle of a Rare But Serious Disease
  • Suspect Adult Respiratory Papillomatosis with Recurrent Hoarseness after Surgery
  • Recurrent Respiratory Papillomatosis: Much Has Been Done, but a Long Road Lies Ahead
  • Prevalence of Dysplasia with Recurrent Respiratory Papillomatosis Is High

The Triological SocietyENTtoday is a publication of The Triological Society.

The Laryngoscope
Ensure you have all the latest research at your fingertips; Subscribe to The Laryngoscope today!

Laryngoscope Investigative Otolaryngology
Open access journal in otolaryngology – head and neck surgery is currently accepting submissions.

Classifieds

View the classified ads »

TRIO Best Practices

View the TRIO Best Practices »

Top Articles for Residents

  • Do Training Programs Give Otolaryngology Residents the Necessary Tools to Do Productive Research?
  • Why More MDs, Medical Residents Are Choosing to Pursue Additional Academic Degrees
  • What Physicians Need to Know about Investing Before Hiring a Financial Advisor
  • Tips to Help You Regain Your Sense of Self
  • Should USMLE Step 1 Change from Numeric Score to Pass/Fail?
  • Popular this Week
  • Most Popular
  • Most Recent
    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment
    • Experts Delve into Treatment Options for Laryngopharyngeal Reflux
    • Vertigo in the Elderly: What Does It Mean?
    • Some Laryngopharyngeal Reflux Resists PPI Treatment
    • Is Middle Ear Pressure Affected by Continuous Positive Airway Pressure Use?
    • Vertigo in the Elderly: What Does It Mean?
    • New Developments in the Management of Eustachian Tube Dysfunction
    • Some Laryngopharyngeal Reflux Resists PPI Treatment
    • Eustachian Tuboplasty: A Potential New Option for Chronic Tube Dysfunction and Patulous Disease
    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment
    • Why Virtual Grand Rounds May Be Here to Stay
    • Otolaryngologist Leverages His Love of Pinball into Second Business
    • These New Imaging Advances May Help to Protect Parathyroids
    • Is the Training and Cost of a Fellowship Worth It? Here’s What Otolaryngologists Say
    • Which Otologic Procedures Poses the Greatest Risk of Aerosol Generation?

Polls

Have you used 3D-printed materials in your otolaryngology practice?

View Results

Loading ... Loading ...
  • Polls Archive
  • Home
  • Contact Us
  • Advertise
  • Privacy Policy
  • Terms of Use

Visit: The Triological Society • The Laryngoscope • Laryngoscope Investigative Otolaryngology

Wiley
© 2021 The Triological Society. All Rights Reserved.
ISSN 1559-4939

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.